Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Angiogenesis in the endometrium.

M C Rees1, R Bicknell

  • 1Nuffield Department of Obstetrics and Gynaecology, Imperial Cancer Research Fund, Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, UK.

Angiogenesis
|October 1, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multimerin-2 is a ligand for group 14 family C-type lectins CLEC14A, CD93 and CD248 spanning the endothelial pericyte interface.

Oncogene·2017
Same author

Proline-Rich Homeodomain protein (PRH/HHEX) is a suppressor of breast tumour growth.

Oncogenesis·2017
Same author

Blocking CLEC14A-MMRN2 binding inhibits sprouting angiogenesis and tumour growth.

Oncogene·2015
Same author

Identification of novel vascular targets in lung cancer.

British journal of cancer·2014
Same author

The effects of CCR5 inhibition on regulatory T-cell recruitment to colorectal cancer.

British journal of cancer·2014
Same author

Differential cavitation, angiogenesis and wound-healing responses in injured mouse and rat spinal cords.

Neuroscience·2014
Same journal

Endothelial Notch1 drives multicellular remodelling during hyaloid vessel regression.

Angiogenesis·2026
Same journal

Endothelial protein C receptor and the endothelial progenitor paradigm: towards a functional definition at last.

Angiogenesis·2026
Same journal

Tumour endothelial cell reprogramming orchestrates angiocrine signalling to drive chemoresistance in breast cancer.

Angiogenesis·2026
Same journal

A possible microvascular vulnerability in carotid artery dissection: insights from nailfold capillaroscopy.

Angiogenesis·2026
Same journal

miR-150 controls developmental angiogenesis via ribosome biogenesis-dependent regulation of Notch signaling.

Angiogenesis·2026
Same journal

MCC links Wnt/PCP signaling to endothelial polarity and vascular remodeling.

Angiogenesis·2026
See all related articles

Human endometrial angiogenesis, crucial for the menstrual cycle, is driven by ovarian steroids stimulating growth factors. Key players identified include vascular endothelial growth factor and platelet-derived endothelial cell growth factor.

Area of Science:

  • Reproductive biology and vascular physiology.

Background:

  • The human endometrium exhibits cyclical, benign angiogenesis regulated by ovarian steroids (estradiol, progesterone).
  • Ovarian steroids lack intrinsic angiogenic activity, instead stimulating angiogenic factors from endometrial epithelium and stroma.
  • Endometrial angiogenesis involves paracrine signaling to the vascular endothelium.

Purpose of the Study:

  • To investigate the mechanisms underlying steroid-hormone-driven endometrial angiogenesis.
  • To identify key molecular mediators of angiogenesis in the human endometrium.
  • To validate the utility of in vitro endometrial cell culture models for mechanistic studies.

Main Methods:

  • Utilizing in vitro models with isolated human endometrial epithelium, stroma, and endothelium.
  • Analyzing the roles of ovarian steroids in modulating angiogenic factor release.

Related Experiment Videos

  • Investigating the effects of specific growth factors on endothelial cells.

    • Main Results:

    • Ovarian steroids stimulate the release of angiogenic factors from stromal and epithelial cells.
    • Vascular endothelial growth factor (VEGF) and platelet-derived endothelial cell growth factor/thymidine phosphorylase (PD-ECGF/TP) were identified as critical mediators.
    • These factors act on endothelial cells to promote angiogenesis.

    Conclusions:

    • Endometrial angiogenesis is a complex process mediated by paracrine signaling.
    • VEGF and PD-ECGF/TP are key molecular players in this angiogenesis.
    • In vitro models are effective for dissecting the mechanisms of endometrial angiogenesis.